Validation of new biomarkers in systemic autoimmune diseases

Biomarkers for Osteoporosis Management

(2012) Patrick Garnero   Molecular Diagnosis & Therapy

Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis

(2010) L. H. D. van Tuyl et al.   ANNALS OF THE RHEUMATIC DISEASES

Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus

(2010) Amy H. Kao et al.   ARTHRITIS AND RHEUMATISM

Uncoupling of Collagen II Metabolism in Newly Diagnosed, Untreated Rheumatoid Arthritis Is Linked to Inflammation and Antibodies Against Cyclic Citrullinated Peptides

(2010) A. F. CHRISTENSEN et al.   JOURNAL OF RHEUMATOLOGY

Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus

(2010) JP Lanoix et al.   LUPUS

Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus

(2010) Kazuhiro Kurasawa et al.   Modern Rheumatology

Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases

(2010) Maria G Tektonidou et al.   ARTHRITIS RESEARCH & THERAPY

Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease

(2009) D-Y Chen et al.   ANNALS OF THE RHEUMATIC DISEASES

Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor α in a subset of normal and systemic sclerosis patient sera

(2009) Nick Loizos et al.   ARTHRITIS AND RHEUMATISM

Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis

(2009) Jean-François Classen et al.   ARTHRITIS AND RHEUMATISM

Autoantibodies against the platelet-derived growth factor receptor in scleroderma: Comment on the articles by Classen et al and Loizos et al

(2009) Armando Gabrielli et al.   ARTHRITIS AND RHEUMATISM

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study

(2009) Jason W. Bauer et al.   ARTHRITIS AND RHEUMATISM

The search for lupus biomarkers

(2009) Chau-Ching Liu et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Cartilage and Bone Biomarkers in Rheumatoid Arthritis: Prediction of 10-year Radiographic Progression

(2009) S. W. SYVERSEN et al.   JOURNAL OF RHEUMATOLOGY

Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria

(2009) W. P. MAKSYMOWYCH et al.   JOURNAL OF RHEUMATOLOGY

Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design

(2009) W. P. MAKSYMOWYCH et al.   JOURNAL OF RHEUMATOLOGY

A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs

(2009) Jun Hashimoto et al.   Modern Rheumatology

Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus

(2009) D.-H. Yang et al.   RHEUMATOLOGY

Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis

(2009) Margaret Wisłowska et al.   RHEUMATOLOGY INTERNATIONAL

Anti-PDGFR-  antibodies measured by non-bioactivity assays are not specific for systemic sclerosis

(2008) E Balada et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis

(2008) H Marotte et al.   ANNALS OF THE RHEUMATIC DISEASES

Lack of association between the interferon-  signature and longitudinal changes in disease activity in systemic lupus erythematosus

(2008) C Landolt-Marticorena et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

(2008) Qiong Fu et al.   ARTHRITIS RESEARCH & THERAPY

Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus

(2007) M Nikpour et al.   ANNALS OF THE RHEUMATIC DISEASES